Physician

Antonio Mesa, D.O.

According to 2025 Medicare claims, Antonio Mesa, D.O. (NPI: 1093717167) practices interventional pain management (ipm) in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is NEUROSCIENCE CONSULTANTS LLP (NPI: 1346217452; TIN: 542107535) and primary practice location at 33155-3710.

Mesa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 163 traditional Medicare patients, billed 1,305 HCPCS/CPT codes, and received $103,061 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 2,714 prescription claims across 471 beneficiaries totaling $59,129 in drug costs, led by Aimovig Autoinjector (Erenumab-Aooe). 2019 DME data shows 38 claims. Open Payments data shows 23 records totaling $1,927. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $160,102 to $59,129. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	248	1,181	$86,422
2016	234	1,216	$88,309
2017	208	1,006	$78,729
2018	221	1,081	$81,958
2019	224	1,222	$108,301
2020	190	1,494	$99,138
2021	225	1,499	$134,748
2022	207	1,271	$120,113
2023	176	974	$86,654
2024	163	1,305	$103,061

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	305	1,930	$160,102
2016	359	2,198	$188,403
2017	516	3,034	$238,829
2018	554	3,332	$255,622
2019	671	3,930	$208,204
2020	634	4,120	$184,904
2021	632	4,022	$123,071
2022	559	3,401	$109,267
2023	542	3,203	$77,051
2024	471	2,714	$59,129

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	38	$1,786
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	52	76	$241
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	45	45	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	117	402	$98
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	82	129	$13
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	45	234	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Aimovig Autoinjector	Erenumab-Aooe	13	510	$11,967
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	387	11,326	$10,332
Gabapentin	Gabapentin	574	19,683	$5,898
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	169	4,818	$4,303
Oxycontin	Oxycodone Hcl	12	360	$3,756

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$1,927	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Antonio Mesa, D.O.?

Tedicare shows public-source Medicare data for Antonio Mesa, D.O. (NPI 1093717167), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Antonio Mesa, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Antonio Mesa, D.O.?

Antonio Mesa, D.O. is linked to NEUROSCIENCE CONSULTANTS LLP (billing NPI 1346217452) in the available physician profile data.

Does Antonio Mesa, D.O. have Open Payments data?

Antonio Mesa, D.O. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.